Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Rextar Pro

K-Number: K242185 · 2024-12-04

Decision Date2024-12-04
Product CodeEHD
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Rextar Pro is the device name listed in this FDA 510(k) record. The listed applicant is Raypia Co., Ltd.. It received FDA 510(k) clearance on 2024-12-04 under 510(k) number K242185. The device is classified under product code EHD. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Rextar Pro?

Rextar Pro is a medical device that received FDA 510(k) clearance on 2024-12-04. The listed applicant is Raypia Co., Ltd.. The 510(k) number is K242185.

When did Rextar Pro receive FDA 510(k) clearance?

Rextar Pro received FDA 510(k) clearance on 2024-12-04, under 510(k) number K242185.

Who is the listed applicant for Rextar Pro?

The FDA 510(k) record lists Raypia Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Rextar Pro?

The FDA product code for Rextar Pro is EHD.

Related Devices (Code: EHD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.